REGENXBIO Inc.RGNXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-126.38M
↓ 46% vs avg
Percentile
P25
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-86.47M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-126.38M | +28.0% |
| 2024 | $-175.56M | +23.1% |
| 2023 | $-228.37M | +4.1% |
| 2022 | $-238.21M | -276.8% |
| 2021 | $134.70M | +266.4% |
| 2020 | $-80.93M | +32.2% |
| 2019 | $-119.42M | -230.7% |
| 2018 | $91.37M | +240.2% |
| 2017 | $-65.15M | -14.9% |
| 2016 | $-56.71M | - |